-
Utilization and adverse outcomes of fluconazole during pregnancy
In this large study of 4,103,700 pregnant women, fluconazole use during pregnancy was associated with an increased risk of fetal death, but not congenital malformation, relative to use of vaginal azole antifungals.
Q16-09Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s Disease
Current use of domperidone may increase the risk of ventricular tachyarrhythmia and sudden cardiac death (VT/SCD) in patients with Parkinson’s disease, particularly those with a history of cardiovascular disease.
Q13-02Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
There is low compliance to the isotretinoin pregnancy prevention program in Canada.
Q10-23Applying targeted maximum likelihood estimation to pharmacoepidemiology
We illustrate the practical implementation of a newly proposed double robust estimator “Targeted Maximum Likelihood Estimation” (TMLE) and demonstrated its application in common pharmacoepidemiological settings. A real-word example using the clinical practice research datalink is used with a high-dimensional covariate space.
Observational studies of drug safety in multi-database studies: Methodological challenges and opportunities
We review some methodological challenges facing drug safety networks such as CNODES and Sentinel.
Confounding by drug formulary restriction in pharmacoepidemiologic research
We illustrate the confounding that can occur due to drug formulary restrictions using the example of fluticasone/salmeterol combination therapy, whose use is restricted in the province of Quebec, Canada. We found that formulary restrictions can result in substantial and unexpected confounding and should be considered during the design and analysis of pharmacoepidemiologic studies.